Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Completed · Phase 2/Phase 3

Conditions studied: Kidney Transplantation

In brief

The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.

Key facts

Study ID

NCT00099749

Run by

Novartis Pharmaceuticals

People needed

255

Starts

2003-11-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and Female
• Between 18 to 65 years old

You may not qualify if…

• Patients in need of multiple organ transplants

Where it is running

• Loyola University Medical Center — Maywood, Illinois, United States
• SIU School of Medicine — Springfield, Illinois, United States
• St. Barnabas Medical Center — Livingston, New Jersey, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.